{
    "b0": "the 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia",
    "b1": "Familial myelodysplastic syndromes: a review of the literature",
    "b2": "Incidence and burden of the myelodysplastic syndromes",
    "b3": "Myelodysplastic syndromes: incidence and survival in the United States",
    "b4": "Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010",
    "b5": "Revised international prognostic scoring system for myelodysplastic syndromes",
    "b6": "Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System",
    "b7": "Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)",
    "b8": "Clinical effect of point mutations in myelodysplastic syndromes",
    "b9": "",
    "b10": "Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes",
    "b11": "Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo",
    "b12": "age-related clonal hematopoiesis associated with adverse outcomes",
    "b13": "AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation",
    "b14": "involvement and functional impairment of the cd34(+)cd38(-)thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8",
    "b15": "Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level",
    "b16": "A targeted mutational landscape of angioimmunoblastic T-cell lymphoma",
    "b17": "TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis",
    "b18": "Myelodysplastic syndromes: diagnosis and treatment",
    "b19": "Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis",
    "b20": "Age-related mutations associated with clonal hematopoietic expansion and malignancies",
    "b21": "clonal hematopoiesis and blood-cancer risk inferred from blood dna sequence",
    "b22": "Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes",
    "b23": "Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression",
    "b24": "MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance",
    "b25": "Landscape of genetic lesions in 944 patients with myelodysplastic syndromes",
    "b26": "Clinical and biological implications of driver mutations in myelodysplastic syndromes",
    "b27": "Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing",
    "b28": "acute myeloid leukemia ontogeny is defined by distinct somatic mutations",
    "b29": "Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission",
    "b30": "NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes",
    "b31": "Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML",
    "b32": "The origin and evolution of mutations in acute myeloid leukemia",
    "b33": "Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes",
    "b34": "Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms",
    "b35": "Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation",
    "b36": "effect of mutation order on myeloproliferative neoplasms",
    "b37": "Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations",
    "b38": "SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts",
    "b39": "Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing",
    "b40": "Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse",
    "b41": "Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia",
    "b42": "Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia",
    "b43": "Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia",
    "b44": "Clonal diversity of recurrently mutated genes in myelodysplastic syndromes",
    "b45": "Somatic mutations and clonal hematopoiesis in aplastic anemia",
    "b46": "Signatures of mutational processes in human cancer",
    "b47": "Patterns of somatic mutation in human cancer genomes",
    "b48": "Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome",
    "b49": "Discovery and saturation analysis of cancer genes across 21 tumour types",
    "b50": "Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis",
    "b51": "Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes",
    "b52": "Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts",
    "b53": "Frequent pathway mutations of splicing machinery in myelodysplasia",
    "b54": "",
    "b55": "Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts",
    "b56": "Cancer-associated SF3B1 hotspot mutations induce cryptic 3' splice site selection through use of a different branch point",
    "b57": "SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition",
    "b58": "U2AF1 mutations alter splice site recognition in hematological malignancies",
    "b59": "Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms",
    "b60": "DNMT3A in haematological malignancies",
    "b61": "DNMT3A mutations in acute myeloid leukemia",
    "b62": "Recurrent DNMT3A mutations in patients with myelodysplastic syndromes",
    "b63": "TET proteins and 5-methylcytosine oxidation in hematological cancers",
    "b64": "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1",
    "b65": "TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)",
    "b66": "lcx, leukemia-associated protein with a cxxc domain, is fused to mll in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23)",
    "b67": "Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases",
    "b68": "Tet2 facilitates the derepression of myeloid target genes during CEBP\u03b1-induced transdifferentiation of pre-B cells",
    "b69": "Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis",
    "b70": "tet2 mutations affect non-cpg island dna methylation at enhancers and transcription factor-binding sites in chronic myelomonocytic leukemia",
    "b71": "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate",
    "b72": "the common feature of leukemia-associated idh1 and idh2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate",
    "b73": "oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases",
    "b74": "(r)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible",
    "b75": "idh mutation impairs histone demethylation and results in a block to cell differentiation",
    "b76": "Dnmt3a is essential for hematopoietic stem cell differentiation",
    "b77": "DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells",
    "b78": "Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation",
    "b79": "Large conserved domains of low DNA methylation maintained by Dnmt3a",
    "b80": "Role of histone H3 lysine 27 methylation in Polycomb-group silencing",
    "b81": "Chromatin compaction by a polycomb group protein complex",
    "b82": "Role of histone H2A ubiquitination in Polycomb silencing",
    "b83": "Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation",
    "b84": "PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes",
    "b85": "Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets",
    "b86": "bcor, a novel corepressor involved in bcl-6 repression",
    "b87": "BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders",
    "b88": "Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB",
    "b89": "ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression",
    "b90": "cancer-associated asxl1 mutations may act as gain-of-function mutations of the asxl1-bap1 complex",
    "b91": "BCOR regulates myeloid cell proliferation and differentiation",
    "b92": "Genetic alterations of the cohesin complex genes in myeloid malignancies",
    "b93": "Cohesin in cancer: chromosome segregation and beyond",
    "b94": "Cohesin-dependent regulation of Runx genes",
    "b95": "Cohesin mutations in myeloid malignancies: underlying mechanisms",
    "b96": "Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development",
    "b97": "Leukemia-associated cohesin mutants dominantly enforce stem cell programs and impair human hematopoietic progenitor differentiation",
    "b98": "Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia",
    "b99": "The RUNX family: developmental regulators in cancer",
    "b100": "Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy",
    "b101": "Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype",
    "b102": "Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy",
    "b103": "An early haematopoietic defect in mice lacking the transcription factor GATA-2",
    "b104": "TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients",
    "b105": "DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia",
    "b106": "WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation",
    "b107": "17p deletion in acute myeloid leukemia and myelodysplastic syndrome. analysis of breakpoints and deleted segments by fluorescence in situ",
    "b108": "TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome",
    "b109": "Intrinsic tumour suppression",
    "b110": "TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities",
    "b111": "Somatic mosaic mutations in PPM1D and TP53 in the blood of women with ovarian carcinoma",
    "b112": "role of tp53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia",
    "b113": "p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal",
    "b114": "Irradiation selects for p53-deficient hematopoietic progenitors",
    "b115": "Clonal architecture of secondary acute myeloid leukemia",
    "b116": "identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product",
    "b117": "The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials",
    "b118": "A gain-of-function mutation of JAK2 in myeloproliferative disorders",
    "b119": "Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies",
    "b120": "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients",
    "b121": "Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms",
    "b122": "Flt3-dependent transformation by inactivating c-Cbl mutations in AML",
    "b123": "Ubiquitination and degradation of the thrombopoietin receptor c-Mpl",
    "b124": "CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN",
    "b125": "New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients",
    "b126": "Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia",
    "b127": "Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution",
    "b128": "Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome",
    "b129": "deletion 5q mds: molecular and therapeutic implications",
    "b130": "Distinct haematological disorder with deletion of long arm of no. 5 chromosome",
    "b131": "Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice",
    "b132": "coordinate loss of a microrna and protein-coding gene cooperate in the pathogenesis of 5q- syndrome",
    "b133": "identification of mir-145 and mir-146a as mediators of the 5q- syndrome phenotype",
    "b134": "Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice",
    "b135": "Role of nucleophosmin in embryonic development and tumorigenesis",
    "b136": "Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling",
    "b137": "Loss of RhoB expression enhances the myelodysplastic phenotype of mammalian diaphanous-related Formin mDia1 knockout mice",
    "b138": "Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis",
    "b139": "Inherited and somatic defects in DDX41 in myeloid neoplasms",
    "b140": "Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS",
    "b141": "identification of rps14 as a 5q- syndrome gene by rna interference screen",
    "b142": "a p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome",
    "b143": "Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9",
    "b144": "Altered translation of GATA1 in Diamond-Blackfan anemia",
    "b145": "diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome",
    "b146": "Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS",
    "b147": "lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion",
    "b148": "Identification of a primary target of thalidomide teratogenicity",
    "b149": "MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia",
    "b150": "CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia",
    "b151": "Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes",
    "b152": "Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study",
    "b153": "Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study",
    "b154": "Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms",
    "b155": "clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression",
    "b156": "Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q",
    "b157": "Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis",
    "b158": "Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation",
    "b159": "Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML",
    "b160": "Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation",
    "b161": "Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia",
    "b162": "Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies",
    "b163": "Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins",
    "b164": "Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML",
    "b165": "SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations",
    "b166": "Age-related mutations and chronic myelomonocytic leukemia",
    "b167": "Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia",
    "b168": "Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria",
    "b169": "Inherited bone marrow failure syndromes in adolescents and young adults",
    "b170": "Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome",
    "b171": "Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia",
    "b172": "A telomerase component is defective in the human disease dyskeratosis congenita",
    "b173": "Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC",
    "b174": "Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia",
    "b175": "Li-Fraumeni syndrome: cancer risk assessment and clinical management",
    "b176": "Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome",
    "b177": "Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)",
    "b178": "novel germ line ddx41 mutations define families with a lower age of mds/aml onset and lymphoid malignancies",
    "b179": "Mutations in SBDS are associated with Shwachman-Diamond syndrome",
    "b180": "Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research",
    "b181": "Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness",
    "b182": "Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells",
    "b183": "Endochondral ossification is required for haematopoietic stem-cell niche formation",
    "b184": "Endothelial and perivascular cells maintain haematopoietic stem cells",
    "b185": "Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow",
    "b186": "Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia",
    "b187": "leukaemogenesis induced by an activating \u03b2-catenin mutation in osteoblasts",
    "b188": "Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche",
    "b189": "Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process",
    "b190": "Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes",
    "b191": "A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome",
    "b192": "Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy",
    "b193": "Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia",
    "b194": "Prognostic relevance of integrated genetic profiling in acute myeloid leukemia",
    "b195": "Genomic Classification and Prognosis in Acute Myeloid Leukemia",
    "b196": "The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes",
    "b197": "a randomized phase 3 study of lenalidomide versus placebo in rbc transfusion-dependent patients with low-/intermediate-1-risk myelodysplastic syndromes with del5q",
    "b198": "Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome",
    "b199": "Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact",
    "b200": "Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features",
    "b201": "Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome?"
}